Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
HOUSE FDA REFORM BILL'S "SCOPE OF REVIEW," THIRD-PARTY PROVISIONS COULD BE CHANGED BEFORE SEPT. 25 COMMITTEE MARK-UP; HEALTH SUBCMTE. CLEARS BILL SEPT. 17
Sep 22 1997
More from Archive
More from Medtech Insight